Tennessee Pharmacists Association

State Naloxone CPP banner


Pharmacist-Provided Opioid Antagonist Law

Public Chapter 596 authorizes the Tennessee Department of Health’s Chief Medical Officer to implement a statewide collaborative pharmacy practice agreement (CPPA) specific to opioid antagonist therapy with any pharmacist licensed and practicing in Tennessee. Pharmacists licensed and practicing in Tennessee are authorized under a valid statewide CPPA executed by the Chief Medical Officer to dispense an opioid antagonist to a person at risk of experiencing an opiate-related overdose or to a family member, friend, or other person in a position to assist a person at risk of experiencing an opiate-related overdose.

Opioid Antagonist Statewide Collaborative Pharmacy Practice Links

Opioid Antagonist Training Program for Pharmacists


Pharmacists must possess an active Tennessee Pharmacist license and be in good standing with the Tennessee Board of Pharmacy. Before a pharmacist enters into a statewide CPPA with the Chief Medical Officer for the dispensing of an opioid antagonist, the pharmacist shall be able to provide documentation of completion of an opioid antagonist training program within the previous two (2) years.

The Tennessee Pharmacists Consortium for Education (TPCE) has created an online, on-demand Opioid Antagonist Training Program for Pharmacists webinar training program. The webinar is available to be completed at any time and meets the requirements established by the Tennessee Department of Health for pharmacists to enter into a statewide CPPA for the dispensing of opioid antagonists. Visit the This webinar training program is available on the TPCE website.

Please note that you will need to create an account on the TPCE website to register for the Opioid Antagonist Training Program for Pharmacists training program. This one-hour online webinar is offered at no cost, but pharmacists have the option to pay $10 to receive one-hour of home study ACPE-accredited continuing education (CE) credit for this approved training course. The program is a knowledge-based activity for those who are interested in learning more about opioid antagonists and the statewide CPPA. TPA thanks Peter Chyka, PharmD, DABAT, FAACT, Professor of Clinical Pharmacy, University of Tennessee Health Science Center College of Pharmacy, Wesley Geminn, PharmD, BCPP, Chief Pharmacist and State Opioid Treatment Authority, Tennessee Department of Mental Health and Substance Abuse Services, and Lucy Adkins Shell, PharmD, TPA Director of Pharmacy Practice Initiatives, for their time and efforts in producing this training program.